Text Size

Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jose Telich, Instituto Nacional de Cardiologia Ignacio Chavez
ClinicalTrials.gov Identifier:
NCT01532167
First received: February 8, 2012
Last updated: March 23, 2012
Last verified: March 2012
History of Changes
  Purpose

The purpose of this study is to demonstrate that [18F]FDG PET is a a better method than clinical and laboratory values for the identification and assessment of inflammatory activity in patients with Takayasu Arteritis (TA), allowing long-term follow-up with a precise evaluation of response to therapy.


Condition
Takayasu Arteritis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact and Utility of Positron Emission Tomography (PET) for the Assessment of Inflammatory Activity Arteritis Versus Clinical Score and Laboratory Values in Takayasu Arteritis: a Cohort Study

Further study details as provided by Instituto Nacional de Cardiologia Ignacio Chavez:

Enrollment: 26
Study Start Date: February 2010
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Detailed Description:

Inflammatory activity and fibrosis are the main causes of morbidity and mortality in patients with Takayasu arteritis. The investigators objective is to determine the utility of using 18F-FDG PET in the basal evaluation and follow-up of patients and compare the results with Dabague's clinical score.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients treated for TA at our institution's immunology outpatient clinic were included between.

Criteria

Inclusion Criteria:

  • TA was diagnosed if the patient met 3 or more ACR criteria.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01532167

Locations
Mexico
Instituto Nacional de Cardiologia
Mexico, DF, Mexico
Sponsors and Collaborators
Instituto Nacional de Cardiologia Ignacio Chavez
Investigators
Principal Investigator: Maria E Soto, MD Instituto Nacional de Cardiologia
Study Director: Erick Alexanderson, MD Instituto Nacional de Cardiologia
  More Information

No publications provided

Responsible Party: Jose Telich, Investigator, Instituto Nacional de Cardiologia Ignacio Chavez
ClinicalTrials.gov Identifier: NCT01532167     History of Changes
Other Study ID Numbers: 12-755
Study First Received: February 8, 2012
Last Updated: March 23, 2012
Health Authority: Mexico: Secretaria de Salud

Additional relevant MeSH terms:
Arteritis
Takayasu Arteritis
Aortic Arch Syndromes
Vascular Diseases
Cardiovascular Diseases
 Vasculitis
Aortic Diseases
Skin Diseases, Vascular
Skin Diseases

ClinicalTrials.gov processed this record on June 18, 2013